IQVIA Holdings Inc.
IQV Healthcare Diagnostics & Research
IQVIA Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $16.3 billion, up 5.87% from fiscal 2024. In the quarter to June 2026, revenue grew 8.74%, EPS was flat, free cash flow grew 23.3% and total debt rose 3.29%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years.
Follow IQV
IQVIA Holdings Inc. (IQV) Revenue growth
IQVIA Holdings Inc.'s revenue growth over the twelve months to 30 June 2026 was 8.17%, up 2.3 percentage points from fiscal 2025 (5.87%). Over the past ten years it has ranged from 2.44% (fiscal 2020) to 42.4% (fiscal 2017); the current reading is higher than 55% of that period. That is above the Diagnostics & Research industry median of 7.69% and in line with the Healthcare sector median of 8.27%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 5.87% | 3.06 |
| FY2024 | 2.81% | (1.17) |
| FY2023 | 3.98% | 0.12 |
| FY2022 | 3.86% | (18.28) |
| FY2021 | 22.1% | 19.70 |
| FY2020 | 2.44% | (4.05) |
| FY2019 | 6.49% | (0.83) |
| FY2018 | 7.32% | (35.04) |
| FY2017 | 42.4% | 23.57 |
| FY2016 | 18.8% | 13.72 |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Jun 2026 | 8.74% | 0.33 |
| Mar 2026 | 8.41% | (1.85) |
| Dec 2025 | 10.3% | 5.02 |
| Sep 2025 | 5.24% | (0.08) |
| 42 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| WAT Waters Corporation compare | 52.5% |
| NTRA Natera, Inc. compare | 37.8% |
| IDXX IDEXX Laboratories, Inc. compare | 12.8% |
| DGX Quest Diagnostics Incorporated compare | 9.87% |
| A Agilent Technologies, Inc. compare | 8.60% |
| IQV IQVIA Holdings Inc. | 8.17% |
| MTD Mettler-Toledo International, Inc. compare | 6.91% |
| LH Labcorp Holdings Inc. compare | 6.41% |
| ILMN Illumina, Inc. compare | 4.88% |
| Diagnostics & Research industry median | 7.69% |
| Healthcare sector median | 8.27% |
| Market median | 7.41% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on IQV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement